X Inactivation Lessons from Differentiating Mouse Embryonic Stem Cells by Greta Pintacuda & Andrea Cerase
X Inactivation Lessons from Differentiating Mouse Embryonic
Stem Cells
Greta Pintacuda1 & Andrea Cerase2
Published online: 22 July 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract X chromosome inactivation (XCI) is the dosage
compensation mechanism that evolved in female mammals
to correct the genetic imbalance of X-linked genes between
sexes. X chromosome inactivation occurs in early develop-
ment when one of the two X chromosomes of females is
nearly-completely silenced. Differentiating Embryonic Stem
cells (ESC) are regarded as a useful tool to study XCI, since
they recapitulate many events occurring during early develop-
ment. In this review we aim to summarise the advances in the
field and to discuss the close connection between cell differ-
entiation and X chromosome inactivation, with a particular
focus on mouse ESCs.
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X Chromosome inactivation is the mechanism by which
-therian mammals compensate for the genetic diversity be-
tween males (XY) and females (XX) in relation to the genes
located on the X chromosome. In mouse development, two
waves of X chromosome inactivation have been described. A
first wave occurs from the 2- to 4-cell embryonic stage on-
ward, and it is known as imprinted X inactivation (iXCI) [1].
Imprinted X inactivation always results in the paternal X
being silenced, and it is regarded as the ancestral form of
XCI. Indeed, it is the only form of XCI inmarsupials, in which
it appears to be incomplete and prone to reactivation [2]. In
contrast with marsupials, placental mammals stably maintain
the silencing of the paternal X only in those cells that will form
the extra-embryonic tissues. At the blastocyst stage, the silenc-
ing is in fact reverted and the active state of both Xs is re-
established in the Inner Cell Mass (ICM). After implantation,
the ICM forms the epiblast, which originates the embryo prop-
er, and the primitive endoderm [3]. During epiblast formation,
one of the two X chromosomes is randomly selected to be
inactivated, in a process known as random X inactivation
(rXCI) [1, 4]. Both random and imprinted XCI depend upon
a long non-coding RNA (lncRNA) called Xist (Inactive X
specific transcript), which acts as the master regulator of the
process [5]. Differentiating female ESCs are an excellent
model for studying rXCI as they closely recapitulate the se-
quence of events observed in the developing embryo [6, 7]. In
this review, we focus on what we have learned about rXCI
from ESC models in the context of cell differentiation, at the
chromatin, chromosomal and nuclear level. As significant dif-
ferences in XCI [8, 9] and stem cell biology (see also
Box 1) [10–12], have been described across different mamma-
lian species, in this review we refer specifically to mouse XCI
and to the interplay between the two major lncRNAs regulat-
ing XCI, Xist and Tsix. Since other non-coding RNAs have
been shown to regulate XCI, readers are encouraged to consid-
er the following reviews and articles on the topic [13–15].
Box 1
Totipotency
It is defined as the capability of a given cell to differentiate into all cell
types in the body. Early stages of dividing zygotes are an example of
totipotent cells.
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Pluripotency
Pluripotency is defined as the potential of a cell to generate different cell
types. The greater the number of different cell types, the greater the
pluripotent capacity of the cell. ESCs are pluripotent because they cannot
generate extra embryonic tissues.
Pluripotency factors
Pluripotency factors are a set of transcription factors that regulate the
pluripotent status of the cell by transcriptional (and co-transcriptional)
regulation of pluripotency-associated genes.
Mouse vs. human embryonic stem cell X chromosome inactivation
There are several differences between human ESC (hESC) and
mouse ESC (mESC) in the context of XCI. Indeed, while mouse
ESC have two active X chromosomes, conventional human ESCs
have an active and an inactive chromosome. However, a näive state
of hESC was also described where either two active X chromosomes
present, mix of an active and inactive ones can be observed. Very
importantly, cell culture conditions can be adjusted to enrich for two
active X chromosomes.
Polycomb group proteins (PcGs)
Originally discovered in Drosophila as essential regulators of Hox genes
and body development, they play an essential role in cell differentiation.
Self-renewal
It is defined as the capability of a given cell to go through a number of
divisions while maintaining its identity. Self-renewal is a hallmark of cell
types like ESCs and cancer cells.
ESC culturing
In standard conditions, embryonic stem cells (ESCs) are cultured in high-
serum, LIF-containing medium. Additionally, they can be grown on
fibroblast feeder cells which help maintain ESC pluripotency.
Alternatively, ESCmedium can be replaced by 2i mediumwhich contains
LIF and 2 inhibitors of differentiation, one blocking themitogen-activated
protein kinase signalling (Mek) and the other inhibiting glycogen
synthase kinase-3 pathway (Gsk3).
X chromosome inactivation (XCI)
XCI is divided into two stages: The Establishment and the
Maintenance phase. During the establishment phase, Xist RNA is
transcriptionally up-regulated on one of the two X chromosomes, it
spreads in cis (on the same chromosome it is transcribed from) and
induces gene silencing by recruitment of chromatin and DNA modifiers.
Once the silent state has been established it is maintained through
subsequent cell divisions (maintenance phase) by the multiple layers of
epigenetic modifications present on the inactive X (i.e. repressive histone
modifications, histone exchange, DNA methylation, etc.). Importantly,
maintenance of X chromosome inactivation appears to be largely Xist
independent.
X inactivation models
Different model systems have been used to study XCI and its role in
mammalian development. Differentiating female (XX) ESCs represents
one of the best model systems for studying XCI. In fact, this system
recapitulates quite closely the early stages of XCI described in the
embryo. Female ESCs can be differentiated using retinoic acid, or via LIF
(an anti-differentiation factor) withdrawal. Retinoic acid (RA) treatment
induces transcription of specific target genes triggering the cell to
differentiate. Culturing cells in the absence of LIF (LIF removal)
leads to Embryoid Body (EB) formation. EBs are three-
dimensional multicellular aggregates that may have a non-
homogeneous cell composition. Transgenic ESCs (XX or XY)
bearing an inducible Xist-transgene (Xist-Tg) are another widely-
used model in XCI research. Finally, Mouse Embryonic
Fibroblasts (MEFs) are regarded as a good model for the late
steps of XCI as they are terminally differentiated cells in which X
inactivation has already occurred (maintenance phase).
Nuclear matrix
The nuclear matrix (or nuclear scaffold) is a stable, mash-like
proteinaceous structure providing the framework for chromatin
organization.
Cell Reprogramming
Fully differentiated cells can be reprogrammed to an ESC-like state by
transfecting them with a cocktail of transcription factors (Yamanaka’s
protocol), by fusion of differentiated cells and ESCs, or by nuclear
transfer. Noticeably, reprogrammed female ESCs exist with either 2
active X chromosomes or one active and one inactive X chromosome.
ESCs are characterised by their ability to perpetuate the
pluripotent state and to self-renew. This is achieved through
multiple signalling pathways, transcription factor activities,
and the inhibition of differentiation. In undifferentiated ESCs,
expression of the so-called “pioneer pluripotency factors”
Oct-4, Sox2, and Nanog [16] (Fig. 1a) is critical. These genes
regulate the pluripotent state by acting on thousands of
pluripotency-associated target genes [19, 20]. The Jak-Stat3
signalling pathway is also essential to keep ESCs in an undif-
ferentiated state. In particular, the activation of the Jak-Stat3
pathway by the Leukemia inhibiting factor (LIF) is necessary
and sufficient both to maintain the pluripotent state and to
perpetuate self-renewal [20]. Moreover, pluripotency and
self-renewal can also be maintained by suppressing the sig-
nalling cascades needed for cells to differentiate. In this re-
gard, the Smith's group has shown that cells can be kept in an
undifferentiated state, despite external stimuli, by inhibiting
the Mek and Gsk3 signalling pathways (2i conditions) [21,
22].
Mouse female ESCs have two active X chromosomes, as
the ICM cells from which they derive [23], and their chroma-
tin is mostly de-compacted (Fig. 1a) [24]. Transcriptional up-
regulation of Xist represents the molecular switch that triggers
XCI. This event is regulated by pluripotency factors [25] and
other non-coding RNAs (ncRNA) located in the X-
inactivation center (XIC) [26]. Tsix, for instance, is a long
non-coding RNA (lncRNA) antisense to Xist, and the main
antagonist to Xist transcriptional activation [27, 28]. There-
fore, it is the relative ratio of Xist/Tsix expression which ap-
pears to control the initiation of XCI.
When female ESCs differentiate (Fig. 1b), there is a sto-
chastic fluctuation of the level of pluripotency factors and
master epigenetic regulators such as Polycomb repressive
complexes 1–2 (PRC1-2) [16, 29]. In particular, Oct4 and
Nanog, acting as Xist repressors, are downregulated, resulting
in an increase of Xist transcription [30, 31], although the exact
molecular mechanism is not entirely understood [32, 33]. In
this time window, Rnf12, an X-linked ubiquitin ligase, is up-
regulated and targets for proteosomal degradation Rex1, an
important Tsix activator and Xist repressor [34]. Rex1 degra-
dation allows the binding on the Xist promoter of the Xist
activator YY1, with which competes for binding sites,
resulting in increased Xist expression [17]. The combination
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of these differentiation-induced changes, shifts the balanced
level of expression of Xist and Tsix towards a strong mono-
allelic upregulation of Xist, initiating, de facto, XCI [34]. It is
important to highlight here that the exact role of Rnf12 in
rXCI remains controversial. Indeed, although its up-
regulation in male ESCs leads to abnormal XCI, female
Rnf12+/− mice and ESCs are still able to normally inactivate
the X chromosome, suggesting that additional factors acting
downstream and possibly independently of Rnf12 might be
involved in the process [35]. Moreover, in vitro and in vivo
experiments carried out in mouse and other species show that
monoallelic Xist upregulation may not be happening in all
differentiating cells [8, 36]. Indeed, cells silencing more than
one X chromosome would disappear due to counter-selection
[8, 36].
Exploiting a transcriptionally favourable window of oppor-
tunity, Xist starts to spread in cis using local spatial proximity
(Fig. 1b) [37, 38]. 3D proximity is, therefore, the major deter-
minant of Xist initial spreading over any genomic feature or
chromatin signature [37, 38]. How Xist is able to spread only
in cis is still unknown and remains an object of debate. How-
ever, it is known that HnrnpU/Saf-A, a nuclear scaffold
protein, is necessary for Xist localisation on the inactive X
(Xi) [39]. A recent paper [40] confirmed the direct interaction
between Xist and Saf-A and suggested a possible role a post-
translationally modified form of Saf-a [41, 42]. Alternatively,
Xist could be post-transcriptionally modified (i.e. by RNA
methylation) and the regulation of this process might be im-
portant for Xist in cis-spreading and binding to silencing part-
ners [43]. Noticeably, the mechanism through which Xist in-
duces gene silencing is also still unclear. However, we know
that among the earliest events triggered by Xist up-regulation
are global histone deacetylation and the removal of
H3K4me2-3 marks [44, 45]. As these two events are the ear-
liest detected, it is possible that Xist directly or genetically
interacts with a histone deacetylase complex and/or a lysine
demethylase complex but not with the PRC2 complex, which
is recruited after these events [44, 46, 47]. Another early hall-
mark of Xist silencing is the exclusion of RNA Polymerase II
from the presumptive inactive X chromosome territory [44].
This can be a direct consequence of histone deacetylation and/
or H3K4me2-3 demethylation [48]. In fact, the transcription-
permissive H3K4me3 mark [49, 50] is recognised by TAF3
and plays a role in the recruitment of the transcription
Fig. 1 a) In undifferentiated ESCs, chromatin is decompacted and cells
are in a fully pluripotent state. Pluripotency factors, master epigenetic
regulators (i.e. Polycomb proteins, PRC1/2) are highly expressed and
most of the genome is early replicating. b) Early in differentiation,
pluripotency factors are downregulated, allowing the monoallelic
upregulation of Xist on the future inactive X (Xi). PRC1/2 complexes
are also dowregulated [16], YY1 levels remain constant during
differentiation [17]. Xist spreads in the 3D neighbourhood and recruits
chromatin modifiers like histone deacetylases and/or H3K4me2-3
demethylases to the future inactive X. This recruitment can be either
direct or mediated by an adaptor protein. As a consequence of Xist activ-
ity, RNA Pol II is displaced from actively transcribing promoters. Genes
to be silenced start to be relocated inside theXist-repressive compartment.
c) Removal of RNA Pol II from chromatin allows the recruitment of
Polycomb proteins (PcGs) and DNA methyltransferases (DNMTs). In
particular, the future inactive X becomes enriched for the PRC2 mark
H3K27me3 and begins compacting as a consequence of gene silencing.
Gene relocation is nearly complete at this stage, with only few escapee
genes not internalised. CTCFs may serve as a barrier to protect escapee
genes. The future inactive X also becomes late replicating. d) PRC2mark
(H3K27me2-3) is recognised by PRC1 and this silencing loop is rein-
forced by the addition of H2A119ub1* and histone H2A is replaced by
the silencing-associated histone variant macroH2A. Xist spreading is
complete at this stage. Chromatin compaction has reached its maximal
level and the inactiveX translocates to the proximity of the nuclear lamina
or the nucleolus. In fully differentiated cells, pluripotency factors are very
low. PRC1/2 levels are also usually low. Cell reprogramming can revert
the differentiated state to an ESC-like state (iPSC), which is compatible
with de novo XCI establishment. *Note: PRC1 can be recruited to the
inactive X independently of H3K27me3 mark and it starts to accumulate
at low levels on the inactivating X with a similar dynamic [18]
702 Stem Cell Rev and Rep (2015) 11:699–705
machinery at engaged promoters [51]. PRC2 is also recruited
to the inactive X by the PRC2 co-factor Jarid2 [52] and at this
stage of differentiation PRC2 recruitment is completely Xist-
dependent [53].
Xist expression and localisation during differentiation to
determines which X chromosome will be inactivated. Never-
theless, at this state XCI is fully reversible [53].
As cells differentiate, the X chromosome, like like any
other chromosome, rearranges itself according to the specific
lineage commitment of each cell type [54, 55] (Fig. 1c).
Nanog downregulation, in particular, seems to be crucial for
priming cells towards differentiation [56], although Nanog is
itself dispensable for somatic stem cell pluripotency, as are the
Polycomb Group Repressive Complexes 1–2 (PcGs/PRC1-2)
[57, 58]. During this phase, X-linked genes to be silenced are
actively relocated into the Xist-silent compartment, with the
exception of few escapee genes looping out of it [44]. CTCF
binding may serve as a barrier to prevent escapee genes being
internalised into the inactive compartment [59]. Around day
2–3 of differentiation, Oct-4 and Sox2 are also downregulated
to different extents, depending on the cell differentiation fate
[16]. Namely, cells with higher Sox2 will become neuronal
ectoderm and cells with higher Oct-4 mesoderm [55, 60]. The
future inactive X becomes late replicating [61, 62], while pro-
moter DNAmethylation starts to be established, with different
dynamics on a gene-to-gene basis, depending on Smchd1 ac-
tivity [63]. Moreover, higher chromatin compaction of the
inactivating X chromosome starts to become visible [40]. As
differentiation proceeds, X inactivation becomes fully irre-
versible, mostly due to the differentiation/committed state of
the cells [53].
In fully differentiated cells (Fig. 1d), Xist broadly localises
onto the inactive X chromosome and is mostly enriched on
gene-rich, LINE-poor regions [37, 38]. Gene silencing is stably
maintained by the redundant action of multiple layers of epi-
genetic modifications, such as DNA methylation, Methyl-
CpG-Binding proteins (MBDs), late replication timing, macro
H2A incorporation, PRC1/2 activity [18] and repressive his-
tone modifications [6, 64, 65]. PRC1/2 accumulation is now
stably maintained on the inactive X as a consequence of gene
silencing [48] and a self-reinforcing positive feedback loop
[66]. The inactive X has also reached the maximum level of
chromatin compaction [40], and it is now positioned in the
proximity of the nucleolus or the nuclear envelope [13, 67].
Its position in the nucleus seems to have a role in maintaining
the silent state [67].
The new state is, therefore, locked throughout the life of
the individual. Only in the primordial germ cells (PGCs) is
reverted and two active X chromosomes co-exist in the same
nucleus [68]. Maintenance of the silent state is now largely
Xist-independent [69, 70].
A significant open question in the field is understanding
why Xist expression is not capable of setting up de novo gene-
silencing in fully differentiated cells [53]. The reason for Xist
lack of competency in this context is not completely clear but
it is tempting to speculate that might be due to either the
absence or insufficient expression of accessory proteins re-
quired to establish gene silencing [71]. In this regard, cell
reprogramming experiments (Fig. 1) can revert a fully differ-
entiated cells into induced Pluripotent Stem cells (iPSc), in
which Xist-silencing competency is restored [19]. The transi-
tion from fully differentiated cells to iPSc is interesting in the
light of XCI reactivation. In fact, this process seems to pass
through a series of intermediate states that might be useful for
uncovering new links between Xist silencing and differentia-
tion [72] and finding new potential XCI players. For an over-
view of XCI reversal during cell-reprogramming, the readers
are referred to the following reviews [12, 73, 74].
In conclusion, we believe that better knowledge of how
Xist works will come from discovering and dissecting the
molecular machinery interacting with Xist during the
favourable developmental time window in which silencing is
established [43, 47]. Therefore, studying the role of the pro-
teins that directly or genetically interact with Xist is crucial for
a better understanding of XCI. We predict that these proteins
may also have a key role in cell differentiation.
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ESC Embryonic stem cells
hESC Human embryonic stem cells
H3K4me2-3 Histone 3 lysine 4 di-trimethylation
H3K27me3 Histone 3 lysine 27 trimethylation
ICM Inner cell mass
iPSC Induced pluripotent cells
iXCI Imprinted X chromosome
inactivation
lncRNA Long non-coding RNA
LIF Leukemia inhibitory factor
mESC Mouse embryonic stem cells
MDB Methyl-CpG-binding protein
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ncRNA Non-coding RNA
PcG Polycomb group proteins
PGC Primordial germ cells
Pol II RNA polymerase II
PRC1-2 Polycomb repressive complex 1 & 2




U scaffold attachment factor A/
heterogeneous ribonucleoprotein U
Tsix Antisense transcript to Xist
Xa Active X chromosome
Xi Inactive X chromosome
XIC X-inactivation center (a~350 kb region
around Xist)
Xist Inactive X specific transcript
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